Blink Pharma, the leading platform for managing transactions between healthcare professionals, has successfully concluded its seed round with the Azur Innovation Fund Investment Fund to fund the expansion of its activities, including the introduction of new healthcare products.
With a digital solution to streamline transactions between healthcare professionals (laboratories, wholesalers, and pharmacists) to eliminate bottlenecks, late delivery, and decreased service quality, the Azur Innovation Fund has provided Blink Pharma with its initial funding.
Read also Egyptian B2B2C Health And Wellness Startup Esaal Bags $1.7m In Seed Funding Round
In fact, the business established its marketplace in 2020, which not only allows pharmacists to transfer orders to laboratories and wholesalers, but also facilitates commercial transactions via a system compliant with Law 17–04. The platform also features a news and information area, and more than 3,500 pharmacists have already subscribed to the service.
In addition to this main product, Blink Pharma is creating other digital technologies that provide healthcare professionals with actual answers. Based on the knowledge of Founding Directors Ali Sami, CEO, and Adil Bertul, CCO, in this field, these solutions are a reaction to the recognized obstacles in this sector.
Read also SMEs to Benefit From Telkom Business’ izwe.ai Multilingual Translation Services
“It is our intention to expedite the digital footprint of healthcare services. To broaden our services to the physician and the patient, we began with the pharmacy. Digital technology is significantly transforming the healthcare industry, and we wish to assist stakeholders in this shift. We gain from our extensive understanding of the scientific and regulatory context. However, because we are from the healthcare industry, we also have a high regard for the industry’s ethical standards.
“We are happy to have convinced a big investment fund such as Azur Innovation Fund, which will allow us to realize the full potential of digitization in healthcare,” said Ali Sami, CEO of Blink Pharma.
Read also Egyptian Healthtech Doxx Secures $1.5M Seed For Expansion
The Azur Innovation Fund is a Moroccan seed fund at the service of the Moroccan startup that seeks to optimize the value for all project stakeholders: owners, promoters, collaborators, industrial ecosystem, communities, etc. This is accomplished by an intelligent capital enablement strategy that combines finance, coaching, technical assistance, and oversight.
Blink Pharma Blink Pharma
Charles Rapulu Udoh
Charles Rapulu Udoh is a Lagos-based lawyer, who has several years of experience working in Africa’s burgeoning tech startup industry. He has closed multi-million dollar deals bordering on venture capital, private equity, intellectual property (trademark, patent or design, etc.), mergers and acquisitions, in countries such as in the Delaware, New York, UK, Singapore, British Virgin Islands, South Africa, Nigeria etc. He’s also a corporate governance and cross-border data privacy and tax expert.
As an award-winning writer and researcher, he is passionate about telling the African startup story, and is one of the continent’s pioneers in this regard. You can book a session and speak with him using the link: https://insightsbyexperts.com/view_expert/charles-rapulu-udoh